| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.46e-08 | 20 | 175 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 6.51e-07 | 36 | 175 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RGPD2 RANBP2 RGPD8 AIMP1 DOCK9 PPP1R9A RGPD1 TSC2 RGPD3 AKAP13 PRKCH RIMS1 SOD1 | 3.69e-06 | 360 | 175 | 14 | GO:0051020 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 4.80e-06 | 50 | 175 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 6.79e-06 | 53 | 175 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RGPD2 RANBP2 RGPD8 DOCK9 RGPD1 TSC2 RGPD3 AKAP13 PRKCH RIMS1 SOD1 | 2.75e-05 | 321 | 175 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | protein phosphatase 2B binding | 7.59e-05 | 10 | 175 | 3 | GO:0030346 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 DOCK9 RGPD1 ARHGEF12 TSC2 CCDC88A RGPD3 AKAP13 ARHGAP25 RIMS1 RGPD5 | 1.58e-04 | 507 | 175 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 DOCK9 RGPD1 ARHGEF12 TSC2 CCDC88A RGPD3 AKAP13 ARHGAP25 RIMS1 RGPD5 | 1.58e-04 | 507 | 175 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ARHGEF12 TSC2 RGPD3 ARHGAP25 RGPD5 | 1.83e-04 | 279 | 175 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | Ser-tRNA(Ala) hydrolase activity | 2.28e-04 | 3 | 175 | 2 | GO:0002196 | |
| GeneOntologyMolecularFunction | isomerase activity | 2.99e-04 | 192 | 175 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.00e-04 | 37 | 175 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | alanine-tRNA ligase activity | 4.53e-04 | 4 | 175 | 2 | GO:0004813 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 5.42e-04 | 210 | 175 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 5.51e-04 | 264 | 175 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | keratin filament binding | 1.12e-03 | 6 | 175 | 2 | GO:1990254 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.82e-11 | 9 | 175 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.99e-11 | 10 | 175 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.98e-10 | 20 | 175 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 5.59e-10 | 13 | 175 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 9.72e-10 | 14 | 175 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 TOR1AIP2 RGPD2 RANBP2 RGPD8 SYNE1 RGPD1 TSC2 TRIM29 ABCA7 SIRT1 RGPD3 AKAP1 HDGF RGPD5 | 4.97e-07 | 362 | 175 | 15 | GO:0034504 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 7.54e-07 | 38 | 175 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.36e-06 | 71 | 175 | 7 | GO:0006111 | |
| GeneOntologyBiologicalProcess | RNA localization | RGPD4 RGPD2 RANBP2 A1CF RGPD8 RGPD1 ZC3H11B STAU1 IGF2BP2 RGPD3 STAU2 | 2.57e-06 | 217 | 175 | 11 | GO:0006403 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 6.31e-06 | 54 | 175 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.97e-05 | 185 | 175 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.39e-05 | 145 | 175 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 4.48e-05 | 195 | 175 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 4.54e-05 | 111 | 175 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | protein folding | RGPD4 RGPD2 RANBP2 RGPD8 CANX RGPD1 PFDN2 AARSD1 RGPD3 HSPA9 | 4.97e-05 | 246 | 175 | 10 | GO:0006457 |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 5.51e-05 | 25 | 175 | 4 | GO:2000114 | |
| GeneOntologyBiologicalProcess | import into nucleus | 5.67e-05 | 201 | 175 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 5.69e-05 | 115 | 175 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 7.86e-05 | 121 | 175 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ZC3H11B TSC2 RGPD3 AKAP13 AKAP1 HSPA9 RGPD5 | 9.70e-05 | 378 | 175 | 12 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ZC3H11B TSC2 RGPD3 AKAP13 AKAP1 HSPA9 RGPD5 | 9.70e-05 | 378 | 175 | 12 | GO:0006913 |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 1.15e-04 | 30 | 175 | 4 | GO:0032878 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.28e-04 | 175 | 175 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.28e-04 | 175 | 175 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.36e-04 | 132 | 175 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.43e-04 | 178 | 175 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.49e-04 | 134 | 175 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 RGPD2 RANBP2 RGPD8 ZFYVE16 SYNE1 RGPD1 ZC3H11B TSC2 RUFY3 STAU1 CCDC88A IGF2R DST HOOK1 RGPD3 STAU2 AKAP13 RIMS1 TBC1D23 AKAP1 GRAMD1C CLEC16A TMCC1 HSPA9 SOD1 RGPD5 | 1.56e-04 | 1496 | 175 | 27 | GO:0046907 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RGPD4 TOR1AIP2 CACNA1D RGPD2 RANBP2 ABL2 RGPD8 SPTA1 DOCK9 RGPD1 TSC2 RFC4 HMGN3 SIRT1 GSN GHR FANK1 CCDC88A RGPD3 CRNN PDE5A PRKCH ARHGAP25 CLSPN BCL2L13 SOD1 | 1.86e-04 | 1430 | 175 | 26 | GO:0044093 |
| GeneOntologyBiologicalProcess | anterograde dendritic transport of messenger ribonucleoprotein complex | 2.14e-04 | 3 | 175 | 2 | GO:0098964 | |
| GeneOntologyBiologicalProcess | heart process | 3.20e-04 | 309 | 175 | 10 | GO:0003015 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 TOR1AIP2 RGPD2 RANBP2 RGPD8 ZFYVE16 SYNE1 RGPD1 TSC2 DZIP1 TRIM29 MEAK7 ABCA7 SIRT1 FSIP2 CCDC88A RGPD3 KICS2 AKAP1 HDGF RGPD5 | 3.88e-04 | 1091 | 175 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | alanyl-tRNA aminoacylation | 4.25e-04 | 4 | 175 | 2 | GO:0006419 | |
| GeneOntologyBiologicalProcess | intracellular mRNA localization | 4.46e-04 | 18 | 175 | 3 | GO:0008298 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RGPD4 CACNA1D RGPD2 RANBP2 ABL2 RGPD8 DOCK9 RGPD1 TSC2 RFC4 SIRT1 GSN GHR CCDC88A RGPD3 PDE5A ARHGAP25 CLSPN BCL2L13 SOD1 | 4.70e-04 | 1028 | 175 | 20 | GO:0043085 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.35e-12 | 8 | 177 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 6.91e-11 | 10 | 177 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.61e-10 | 14 | 177 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 5.78e-09 | 18 | 177 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.19e-08 | 20 | 177 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.65e-08 | 21 | 177 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear membrane | RGPD4 AMBP TOR1AIP2 RGPD2 RANBP2 RGPD8 SYNE1 CANX RGPD1 SIRT1 NLRP10 RGPD3 STAU2 | 9.17e-06 | 349 | 177 | 13 | GO:0031965 |
| GeneOntologyCellularComponent | inclusion body | 1.15e-05 | 90 | 177 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 AMBP TOR1AIP2 RGPD2 RANBP2 RGPD8 SYNE1 CANX RGPD1 SIRT1 NLRP10 IGF2R DST RGPD3 STAU2 RGPD5 | 2.36e-05 | 560 | 177 | 16 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear pore | 2.44e-05 | 101 | 177 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 TTF2 RGPD2 RANBP2 A1CF RGPD8 LUC7L3 ORC3 RBBP8 SYNE1 POLR2B RGPD1 NSD1 GON4L CHD3 RFC4 SIRT1 KMT2C RGPD3 MED12L HLTF SMARCC2 UTY CWF19L1 RGPD5 | 2.50e-04 | 1377 | 177 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | dendrite cytoplasm | 3.24e-04 | 39 | 177 | 4 | GO:0032839 | |
| MousePheno | abnormal morula morphology | 5.39e-09 | 26 | 142 | 7 | MP:0012058 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 7.28e-09 | 16 | 142 | 6 | MP:0003701 | |
| MousePheno | decreased tumor latency | 1.61e-08 | 30 | 142 | 7 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 2.06e-08 | 31 | 142 | 7 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 4.12e-08 | 34 | 142 | 7 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 1.13e-07 | 39 | 142 | 7 | MP:0012128 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | RGPD4 RGPD2 RANBP2 RGPD8 RBBP8 POLR2B PARG RGPD1 ZNF407 RGPD3 | 1.29e-07 | 107 | 142 | 10 | MP:0003694 |
| MousePheno | abnormal blastocyst hatching | RGPD4 RGPD2 RANBP2 RGPD8 RBBP8 POLR2B PARG RGPD1 ZNF407 RGPD3 | 2.17e-07 | 113 | 142 | 10 | MP:0003693 |
| MousePheno | abnormal rod electrophysiology | RGPD4 RGPD2 RANBP2 SLC4A7 RGPD8 RGPD1 GPR179 RGPD3 RP1L1 EML1 | 3.53e-07 | 119 | 142 | 10 | MP:0004021 |
| MousePheno | abnormal preimplantation embryo development | RGPD4 AMBP RGPD2 RANBP2 RGPD8 RBBP8 POLR2B PARG RGPD1 ZNF407 RGPD3 | 1.33e-06 | 171 | 142 | 11 | MP:0009781 |
| MousePheno | aneuploidy | 2.66e-06 | 61 | 142 | 7 | MP:0004024 | |
| MousePheno | increased hepatocellular carcinoma incidence | 6.76e-06 | 70 | 142 | 7 | MP:0003331 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.70e-05 | 111 | 142 | 8 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 1.70e-05 | 111 | 142 | 8 | MP:0008019 | |
| MousePheno | abnormal eye electrophysiology | RGPD4 RGPD2 RANBP2 SLC4A7 RGPD8 RGPD1 GPR179 RGPD3 RP1L1 EML1 SOD1 | 2.09e-05 | 228 | 142 | 11 | MP:0005551 |
| MousePheno | abnormal chromosome number | 2.65e-05 | 86 | 142 | 7 | MP:0004023 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | RGPD4 RGPD2 RANBP2 A1CF RGPD8 RBBP8 POLR2B RGPD1 ZNF407 RGPD3 | 4.21e-05 | 203 | 142 | 10 | MP:0011094 |
| MousePheno | abnormal mitosis | 4.77e-05 | 128 | 142 | 8 | MP:0004046 | |
| MousePheno | increased sarcoma incidence | 7.95e-05 | 102 | 142 | 7 | MP:0002032 | |
| MousePheno | abnormal epididymis morphology | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 MEAK7 GHR RGPD3 ZFHX2 CFAP44 TDRD12 | 9.40e-05 | 269 | 142 | 11 | MP:0002631 |
| MousePheno | increased incidence of tumors by chemical induction | 9.46e-05 | 141 | 142 | 8 | MP:0004499 | |
| MousePheno | increased respiratory system tumor incidence | 1.08e-04 | 107 | 142 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 1.08e-04 | 107 | 142 | 7 | MP:0008014 | |
| MousePheno | abnormal glucose tolerance | RGPD4 CACNA1B CACNA1D RGPD2 RANBP2 RGPD8 DSPP RGPD1 AAK1 SERTAD2 HMGN3 SIRT1 TG IGF2BP2 RGPD3 SCN3A AKAP13 NFAT5 SYCE1 PDZD2 | 1.34e-04 | 787 | 142 | 20 | MP:0005291 |
| MousePheno | increased lung carcinoma incidence | 1.39e-04 | 78 | 142 | 6 | MP:0008714 | |
| MousePheno | positive geotaxis | 1.60e-04 | 11 | 142 | 3 | MP:0005356 | |
| MousePheno | increased energy expenditure | RGPD4 CACNA1B RGPD2 RANBP2 RGPD8 RGPD1 SERTAD2 IGF2BP2 RGPD3 | 1.75e-04 | 196 | 142 | 9 | MP:0004889 |
| MousePheno | embryonic lethality before implantation | RGPD4 RGPD2 RANBP2 A1CF RGPD8 RBBP8 POLR2B RGPD1 ZNF407 RGPD3 | 1.81e-04 | 242 | 142 | 10 | MP:0006204 |
| MousePheno | increased carcinoma incidence | 1.82e-04 | 197 | 142 | 9 | MP:0002038 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 2.27e-04 | 160 | 142 | 8 | MP:0005659 | |
| MousePheno | abnormal cell cycle | RGPD4 RGPD2 RANBP2 RGPD8 RBBP8 RGPD1 BIRC6 SIRT1 RGPD3 EML1 CLSPN EIF4G3 AKAP1 SYCE1 TDRD12 | 2.61e-04 | 520 | 142 | 15 | MP:0003077 |
| MousePheno | abnormal epididymis size | 2.91e-04 | 166 | 142 | 8 | MP:0004926 | |
| MousePheno | decreased luteinizing hormone level | 2.94e-04 | 32 | 142 | 4 | MP:0005132 | |
| MousePheno | abnormal chromosome morphology | 2.97e-04 | 126 | 142 | 7 | MP:0003702 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | RGPD4 RGPD2 RANBP2 AARS1 A1CF RGPD8 RBBP8 POLR2B PARG RGPD1 ZNF407 PFDN2 CDC7 BMPR2 WDHD1 RGPD3 PKM DLD ZFR | 3.01e-04 | 772 | 142 | 19 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | RGPD4 RGPD2 RANBP2 AARS1 A1CF RGPD8 RBBP8 POLR2B PARG RGPD1 ZNF407 PFDN2 CDC7 BMPR2 WDHD1 RGPD3 PKM DLD ZFR | 3.37e-04 | 779 | 142 | 19 | MP:0014257 |
| MousePheno | increased incidence of induced tumors | 3.84e-04 | 173 | 142 | 8 | MP:0002021 | |
| MousePheno | abnormal incidence of induced tumors | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 LONP1 RGPD3 NCAPD2 PRKCH CLSPN | 4.21e-04 | 269 | 142 | 10 | MP:0013151 |
| MousePheno | enlarged epididymis | 5.10e-04 | 99 | 142 | 6 | MP:0004931 | |
| MousePheno | decreased circulating thyroxine level | 5.76e-04 | 38 | 142 | 4 | MP:0005478 | |
| MousePheno | novel environmental response-related retropulsion | 6.07e-04 | 4 | 142 | 2 | MP:0005357 | |
| MousePheno | decreased susceptibility to weight gain | 6.22e-04 | 186 | 142 | 8 | MP:0010182 | |
| MousePheno | increased malignant tumor incidence | 7.04e-04 | 237 | 142 | 9 | MP:0002018 | |
| Domain | Ran_BP1 | 3.79e-12 | 12 | 172 | 7 | PF00638 | |
| Domain | RANBD1 | 3.79e-12 | 12 | 172 | 7 | PS50196 | |
| Domain | RanBD | 8.14e-12 | 13 | 172 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 8.14e-12 | 13 | 172 | 7 | IPR000156 | |
| Domain | Grip | 2.49e-10 | 11 | 172 | 6 | SM00755 | |
| Domain | GRIP | 2.49e-10 | 11 | 172 | 6 | PF01465 | |
| Domain | GRIP_dom | 4.93e-10 | 12 | 172 | 6 | IPR000237 | |
| Domain | GRIP | 4.93e-10 | 12 | 172 | 6 | PS50913 | |
| Domain | Rab_bind | 1.29e-09 | 7 | 172 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.29e-09 | 7 | 172 | 5 | IPR032023 | |
| Domain | - | 1.52e-08 | 10 | 172 | 5 | 1.10.220.60 | |
| Domain | TPR-contain_dom | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 TRANK1 RGPD3 CABIN1 UTY RGPD5 | 1.30e-06 | 150 | 172 | 10 | IPR013026 |
| Domain | TPR | 3.07e-06 | 129 | 172 | 9 | SM00028 | |
| Domain | TPR_REGION | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 TRANK1 RGPD3 CABIN1 UTY RGPD5 | 3.09e-06 | 165 | 172 | 10 | PS50293 |
| Domain | TPR | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 TRANK1 RGPD3 CABIN1 UTY RGPD5 | 3.09e-06 | 165 | 172 | 10 | PS50005 |
| Domain | TPR_repeat | 3.96e-06 | 133 | 172 | 9 | IPR019734 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 RGPD8 DOCK9 FRMPD2 RGPD1 ANKS1B ARHGEF12 CADPS RGPD3 AKAP13 ARHGAP25 RGPD5 | 4.18e-05 | 426 | 172 | 14 | IPR011993 |
| Domain | TPR-like_helical_dom | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 TRANK1 RGPD3 CABIN1 UTY RGPD5 | 6.18e-05 | 233 | 172 | 10 | IPR011990 |
| Domain | Znf_FYVE_PHD | 6.61e-05 | 147 | 172 | 8 | IPR011011 | |
| Domain | - | RGPD4 RGPD2 RANBP2 RGPD8 DOCK9 FRMPD2 RGPD1 ANKS1B ARHGEF12 CADPS RGPD3 AKAP13 ARHGAP25 | 7.03e-05 | 391 | 172 | 13 | 2.30.29.30 |
| Domain | - | 1.31e-04 | 207 | 172 | 9 | 1.25.40.10 | |
| Domain | Znf_U1 | 1.38e-04 | 29 | 172 | 4 | IPR003604 | |
| Domain | ZnF_U1 | 1.38e-04 | 29 | 172 | 4 | SM00451 | |
| Domain | SNF2_N | 2.04e-04 | 32 | 172 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.04e-04 | 32 | 172 | 4 | PF00176 | |
| Domain | Ala-tRNA-lgiase_IIc | 2.51e-04 | 3 | 172 | 2 | IPR002318 | |
| Domain | Staufen_C | 2.51e-04 | 3 | 172 | 2 | IPR032478 | |
| Domain | Staufen_C | 2.51e-04 | 3 | 172 | 2 | PF16482 | |
| Domain | PDZ | 3.34e-04 | 141 | 172 | 7 | PF00595 | |
| Domain | PDZ | 4.47e-04 | 148 | 172 | 7 | SM00228 | |
| Domain | - | 4.85e-04 | 150 | 172 | 7 | 2.30.42.10 | |
| Domain | Ala-tRNA-synth_IIc_core | 5.00e-04 | 4 | 172 | 2 | IPR018165 | |
| Domain | Ala-tRNA-synth_IIc_N | 5.00e-04 | 4 | 172 | 2 | IPR018164 | |
| Domain | tRNA-synt_2c | 5.00e-04 | 4 | 172 | 2 | PF01411 | |
| Domain | AA_TRNA_LIGASE_II_ALA | 5.00e-04 | 4 | 172 | 2 | PS50860 | |
| Domain | PDZ | 5.05e-04 | 151 | 172 | 7 | PS50106 | |
| Domain | PDZ | 5.25e-04 | 152 | 172 | 7 | IPR001478 | |
| Domain | Spectrin | 1.19e-03 | 23 | 172 | 3 | PF00435 | |
| Domain | HOOK | 1.23e-03 | 6 | 172 | 2 | PF05622 | |
| Domain | Hook-related_fam | 1.23e-03 | 6 | 172 | 2 | IPR008636 | |
| Domain | PHD | 1.39e-03 | 89 | 172 | 5 | SM00249 | |
| Domain | TPR_1 | 1.46e-03 | 90 | 172 | 5 | IPR001440 | |
| Domain | TPR_1 | 1.46e-03 | 90 | 172 | 5 | PF00515 | |
| Domain | Znf_PHD | 1.53e-03 | 91 | 172 | 5 | IPR001965 | |
| Domain | tRNA_SAD | 1.72e-03 | 7 | 172 | 2 | IPR012947 | |
| Domain | Ca_chan_IQ | 1.72e-03 | 7 | 172 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.72e-03 | 7 | 172 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.72e-03 | 7 | 172 | 2 | IPR014873 | |
| Domain | tRNA_SAD | 1.72e-03 | 7 | 172 | 2 | SM00863 | |
| Domain | GPHH | 1.72e-03 | 7 | 172 | 2 | PF16905 | |
| Domain | DCX | 1.72e-03 | 7 | 172 | 2 | PF03607 | |
| Domain | GPHH_dom | 1.72e-03 | 7 | 172 | 2 | IPR031649 | |
| Domain | tRNA_SAD | 1.72e-03 | 7 | 172 | 2 | PF07973 | |
| Domain | ZF_PHD_2 | 1.86e-03 | 95 | 172 | 5 | PS50016 | |
| Domain | - | 1.91e-03 | 27 | 172 | 3 | 3.30.160.20 | |
| Domain | ZF_PHD_1 | 1.94e-03 | 96 | 172 | 5 | PS01359 | |
| Domain | dsRBD_dom | 2.12e-03 | 28 | 172 | 3 | IPR014720 | |
| Domain | DC | 2.28e-03 | 8 | 172 | 2 | PS50309 | |
| Domain | Thr/Ala-tRNA-synth_IIc_edit | 2.28e-03 | 8 | 172 | 2 | IPR018163 | |
| Domain | Doublecortin_dom | 2.28e-03 | 8 | 172 | 2 | IPR003533 | |
| Domain | Spectrin_repeat | 2.35e-03 | 29 | 172 | 3 | IPR002017 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 6.33e-09 | 18 | 122 | 6 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.10e-07 | 73 | 122 | 8 | MM14948 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.12e-06 | 40 | 122 | 6 | MM14945 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.27e-06 | 92 | 122 | 8 | MM14951 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.30e-06 | 41 | 122 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.51e-06 | 42 | 122 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.74e-06 | 43 | 122 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.98e-06 | 47 | 122 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.83e-06 | 49 | 122 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 4.32e-06 | 50 | 122 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 4.86e-06 | 51 | 122 | 6 | MM15151 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.79e-06 | 82 | 122 | 7 | MM15394 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 7.61e-06 | 55 | 122 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.04e-05 | 58 | 122 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.04e-05 | 58 | 122 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.02e-05 | 65 | 122 | 6 | MM15147 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | RGPD4 RGPD2 RANBP2 RGPD8 ORC3 RBBP8 RGPD1 RFC4 CDC7 RGPD3 CLSPN | 2.30e-05 | 271 | 122 | 11 | MM15388 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.43e-05 | 202 | 122 | 9 | MM15362 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.70e-05 | 84 | 122 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 9.93e-05 | 86 | 122 | 6 | MM15413 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD2 RANBP2 SLC4A7 ABL2 RGPD8 DOCK9 RGPD1 ARHGEF12 CCDC88A DST RGPD3 MTR PDE5A AKAP13 ARHGAP25 | 1.48e-04 | 649 | 122 | 16 | MM15690 |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 1.81e-04 | 61 | 122 | 5 | M48077 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.28e-04 | 100 | 122 | 6 | MM14561 | |
| Pathway | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | 2.54e-04 | 36 | 122 | 4 | MM14687 | |
| Pathway | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | 2.83e-04 | 37 | 122 | 4 | M11153 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.63e-04 | 114 | 122 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 5.31e-04 | 117 | 122 | 6 | MM15387 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RGPD2 RANBP2 RGPD8 ORC3 RBBP8 RGPD1 RFC4 NEDD1 CDC7 HAUS8 RGPD3 NCAPD2 CLSPN | 7.13e-04 | 603 | 122 | 14 | MM14635 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.88e-04 | 129 | 122 | 6 | MM14894 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.09e-03 | 6 | 122 | 2 | M47762 | |
| Pubmed | RGPD4 CACNA1B RGPD2 DLGAP2 RANBP2 SLC4A7 RGPD8 AIMP1 DOCK9 CANX RGPD1 AAK1 ANKS1B RRBP1 GPRIN1 TRIM29 BIRC6 NACAD RUFY3 PPM1G STAU1 PITPNM1 CEP170 LONP1 CCDC88A CADPS RGPD3 GLS STAU2 PKM SMARCC2 DLD RIMS1 EIF4G3 CLEC16A TMCC1 HSPA9 | 1.86e-19 | 1139 | 178 | 37 | 36417873 | |
| Pubmed | PRUNE2 ZNF609 ZFYVE16 ARHGEF12 NACAD TRANK1 MAST4 ZFYVE26 RIMS1 CABIN1 CLEC16A PDZD2 ZNF646 | 8.66e-15 | 104 | 178 | 13 | 9205841 | |
| Pubmed | RGPD4 RGPD2 DLGAP2 RANBP2 RGPD8 SYNE1 CANX PPP1R9A RGPD1 AAK1 ANKS1B NSD1 ARHGEF12 DDN TSC2 GSN CEP170 CCDC88A IGF2R DST HOOK1 RGPD3 SMARCC2 ZFR RIMS1 EML1 CABIN1 HSPA9 | 1.14e-13 | 963 | 178 | 28 | 28671696 | |
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.15e-13 | 7 | 178 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.15e-13 | 7 | 178 | 6 | 11353387 | |
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 30944974 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.15e-13 | 7 | 178 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.15e-13 | 7 | 178 | 6 | 17372272 | |
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 38657106 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 21205196 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 18949001 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 25187515 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 8603673 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 26632511 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 24403063 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 23818861 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 23536549 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 12191015 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 22821000 | ||
| Pubmed | 1.15e-13 | 7 | 178 | 6 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.58e-13 | 8 | 178 | 6 | 21670213 | |
| Pubmed | 4.58e-13 | 8 | 178 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.58e-13 | 8 | 178 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.58e-13 | 8 | 178 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.58e-13 | 8 | 178 | 6 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.37e-12 | 9 | 178 | 6 | 18394993 | |
| Pubmed | 1.37e-12 | 9 | 178 | 6 | 28100513 | ||
| Pubmed | 1.37e-12 | 9 | 178 | 6 | 17887960 | ||
| Pubmed | 1.37e-12 | 9 | 178 | 6 | 11553612 | ||
| Pubmed | 1.37e-12 | 9 | 178 | 6 | 10601307 | ||
| Pubmed | 1.37e-12 | 9 | 178 | 6 | 9733766 | ||
| Pubmed | 1.37e-12 | 9 | 178 | 6 | 28877029 | ||
| Pubmed | 3.41e-12 | 10 | 178 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.41e-12 | 10 | 178 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 3.41e-12 | 10 | 178 | 6 | 8857542 | |
| Pubmed | 3.41e-12 | 10 | 178 | 6 | 21859863 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 ZNF609 RGPD8 ZFYVE16 AIMP1 RBBP8 RGPD1 CHD3 BIRC6 CCDC88A DST RGPD3 GLS ZFHX3 AKAP1 OBI1 | 6.79e-12 | 418 | 178 | 18 | 34709266 | |
| Pubmed | 7.47e-12 | 11 | 178 | 6 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 7.47e-12 | 11 | 178 | 6 | 35771867 | |
| Pubmed | 7.47e-12 | 11 | 178 | 6 | 34110283 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TTF2 RANBP2 AARS1 ZFYVE16 PARG AAK1 GPATCH4 CHD3 RRBP1 RFC4 NEDD1 GPRIN1 STAU1 CEP170 IGF2BP2 DST STAU2 PKM DLD ZFR EIF4G3 AKAP1 HSPA9 PUS7 SOD1 | 1.58e-11 | 934 | 178 | 25 | 33916271 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.75e-11 | 13 | 178 | 6 | 31427429 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD2 RANBP2 ZNF609 RGPD8 TCN1 ORC3 SYNE1 TCP11L1 CANX RGPD1 GPATCH4 PFDN2 RRBP1 NEDD1 TRIM29 SIRT1 CEP170 HAUS8 KANK1 RGPD3 PKM SASS6 SMARCC2 ZFR OBI1 RGPD5 | 4.84e-11 | 1155 | 178 | 27 | 20360068 |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 RBBP8 KRT74 SYNE1 SPTA1 PPP1R9A RGPD1 ANKS1B CHD3 RRBP1 HMGN3 DST HOOK1 RDH11 RGPD3 GLS NCAPD2 PKM SMARCC2 DLD ZFR RIMS1 EIF4G3 OBI1 HSPA9 ZNF292 RGPD5 | 6.19e-11 | 1442 | 178 | 30 | 35575683 | |
| Pubmed | 7.95e-11 | 15 | 178 | 6 | 14697343 | ||
| Pubmed | TTF2 RANBP2 ABL2 ZFYVE16 TMEM51 CANX AAK1 ARHGEF12 RRBP1 GPRIN1 PPM1G STAU1 CEP170 CCDC88A IGF2R DST NCAPD2 PKM EIF4G3 HSPA9 HDGF | 1.19e-10 | 708 | 178 | 21 | 39231216 | |
| Pubmed | AARS1 ZNF609 SLC4A7 RGPD8 ZFYVE16 POLR2B GPATCH8 RRBP1 NEDD1 BIRC6 STAU1 CEP170 HAUS8 KANK1 CCDC88A IGF2R WDHD1 MTR AKAP13 CLSPN AKAP1 | 2.23e-10 | 733 | 178 | 21 | 34672954 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | RGPD4 RGPD2 RANBP2 ZNF609 RGPD8 POLR2B RGPD1 RFC4 KMT2C RGPD3 ZFR | 2.78e-10 | 146 | 178 | 11 | 23892456 |
| Pubmed | 1.15e-09 | 22 | 178 | 6 | 27717094 | ||
| Pubmed | RANBP2 AARS1 CANX NSD1 BIRC6 PPM1G STAU1 CEP170 LONP1 IGF2BP2 IGF2R DST NCAPD2 SLTM SMARCC2 DLD ZFR EIF4G3 HSPA9 | 1.32e-09 | 653 | 178 | 19 | 22586326 | |
| Pubmed | 2.29e-09 | 99 | 178 | 9 | 27746211 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 PPM1G CCDC88A RGPD3 STAU2 AKAP13 SOD1 HDGF | 2.37e-09 | 226 | 178 | 12 | 37839992 |
| Pubmed | TTF2 RANBP2 AARS1 ZNF609 ORC3 PFDN2 CHD3 RFC4 NEDD1 SIRT1 GSN PPM1G STAU1 CEP170 KMT2C IGF2BP2 PKM HLTF SMARCC2 ZFR USF2 HSPA9 ZNF292 HDGF | 2.61e-09 | 1103 | 178 | 24 | 34189442 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RANBP2 AARS1 SLC4A7 LUC7L3 AIMP1 CANX POLR2B TSC2 GPATCH4 PFDN2 RRBP1 RFC4 BIRC6 GSN PPM1G CEP170 LONP1 NCAPD2 PKM HLTF SMARCC2 AKAP13 CWF19L1 HSPA9 PUS7 HDGF SPINK5 | 4.01e-09 | 1415 | 178 | 27 | 28515276 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 AARS1 LUC7L3 AIMP1 TCP11L1 CANX POLR2B PFDN2 RFC4 GSN PPM1G STAU1 CEP170 IGF2BP2 DST HOOK1 STAU2 NCAPD2 PKM EIF4G3 OBI1 HSPA9 SOD1 HDGF | 5.76e-09 | 1149 | 178 | 24 | 35446349 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 ZNF609 LUC7L3 AIMP1 PPP1R9A FRMPD2 AAK1 CHD3 RRBP1 NEDD1 PCNX2 CEP170 KMT2C BMPR2 PLXDC2 RDH11 SHPRH ZFHX2 AKAP13 ZFHX3 RIMS1 EIF4G3 NFAT5 CLEC16A TMCC1 PDZD2 FAM149A | 1.17e-08 | 1489 | 178 | 27 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TOR1AIP2 TTF2 SLC4A7 RGPD8 LUC7L3 SYNE1 CANX POLR2B TSC2 GPATCH4 RRBP1 BIRC6 SIRT1 STAU1 LONP1 IGF2BP2 DST GLS STAU2 MTR SASS6 ZFR PRKCH AKAP1 BCL2L13 TMCC1 HSPA9 | 1.29e-08 | 1496 | 178 | 27 | 32877691 |
| Pubmed | SLC4A7 PUS3 GPATCH4 GPRIN1 BIRC6 RUFY3 PPM1G CCDC88A IGF2R DST PKM ZFR PRKCH ZFHX3 CLSPN EIF4G3 AKAP1 CLEC16A HSPA9 | 2.17e-08 | 777 | 178 | 19 | 35844135 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 TOR1AIP2 TTF2 RGPD2 RANBP2 RGPD8 AIMP1 CANX POLR2B PBDC1 RGPD1 TSC2 RRBP1 RFC4 BIRC6 PPM1G CDC7 RGPD3 PKM HLTF MTR DLD HSPA9 RGPD5 | 3.17e-08 | 1257 | 178 | 24 | 37317656 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD4 CACNA1B RGPD2 RANBP2 RGPD8 RGPD1 TSC2 GPRIN1 RGPD3 SMARCC2 RIMS1 | 3.44e-08 | 231 | 178 | 11 | 16452087 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 AARS1 AIMP1 CANX AAK1 RFC4 GPRIN1 AARSD1 GSN PPM1G STAU1 CEP170 IGF2BP2 IGF2R RDH11 STAU2 NCAPD2 SLTM PKM DLD ZFR HSPA9 PUS7 SOD1 HDGF | 3.67e-08 | 1367 | 178 | 25 | 32687490 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.98e-08 | 38 | 178 | 6 | 12791264 | |
| Pubmed | AARS1 ZNF609 LUC7L3 ORC3 PARG GON4L CHD3 RRBP1 CCDC88A DST SLTM HLTF MTR AKAP13 CLSPN CLEC16A CWF19L1 | 4.80e-08 | 650 | 178 | 17 | 38777146 | |
| Pubmed | TOR1AIP2 SLC4A7 ABL2 ZFYVE16 CANX GPATCH4 PFDN2 GPRIN1 STAU1 HAUS8 IGF2BP2 IGF2R WDHD1 GLS STAU2 ZFR TBC1D23 AKAP1 CWF19L1 HSPA9 HDGF | 5.73e-08 | 1007 | 178 | 21 | 34597346 | |
| Pubmed | RANBP2 AARS1 ORC3 POLR2B CHD3 GPATCH8 RRBP1 RFC4 HMGN3 SIRT1 PPM1G LONP1 WDHD1 NCAPD2 SLTM HLTF SMARCC2 ZFR CWF19L1 PUS7 HDGF | 6.44e-08 | 1014 | 178 | 21 | 32416067 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RGPD2 RANBP2 RGPD8 ORC3 RGPD1 AAK1 GPATCH4 GSN RGPD3 SLTM SMARCC2 EIF4G3 | 6.90e-08 | 370 | 178 | 13 | 22922362 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 LUC7L3 SYNE1 CANX PPP1R9A POLR2B CHD3 RRBP1 F5 GSN STAU1 CEP170 LONP1 IGF2BP2 IGF2R DST SLTM PKM SMARCC2 ZFR HSPA9 | 7.59e-08 | 1024 | 178 | 21 | 24711643 |
| Pubmed | DLGAP2 PDE1C SYNE1 SPTA1 PPP1R9A AAK1 ANKS1B ARHGEF12 CHD3 RRBP1 RUFY3 GSN STAU1 PITPNM1 CEP170 LONP1 DST CADPS PKM SMARCC2 DLD RIMS1 EIF4G3 HSPA9 SOD1 | 8.80e-08 | 1431 | 178 | 25 | 37142655 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTF2 RANBP2 ABL2 POLR2B RGPD1 AAK1 PFDN2 NEDD1 HAUS8 LONP1 CCDC88A IGF2R MAST4 HOOK1 SASS6 DLD TBC1D23 CLEC16A HSPA9 | 9.35e-08 | 853 | 178 | 19 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AARS1 SLC4A7 ABL2 AAK1 TSC2 DZIP1 CEP170 FSIP2 HAUS8 BMPR2 CCDC88A DST MAST4 HOOK1 AKAP13 EIF4G3 AKAP1 OBI1 TMCC1 | 1.08e-07 | 861 | 178 | 19 | 36931259 |
| Pubmed | ZNF609 AAK1 SERTAD2 DZIP1 RRBP1 NACAD RUFY3 KMT2C CCDC88A TRANK1 DST MAST4 NCAPD2 MED12L ZNF646 | 1.09e-07 | 529 | 178 | 15 | 14621295 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TTF2 RANBP2 AARS1 POLR2B AAK1 GPATCH4 RRBP1 RFC4 BIRC6 AARSD1 STAU1 LONP1 IGF2BP2 DST RDH11 GLS NCAPD2 SLTM PKM HLTF SMARCC2 AKAP13 ZFR HSPA9 | 1.24e-07 | 1353 | 178 | 24 | 29467282 |
| Pubmed | TOR1AIP2 SLC4A7 SYNE1 CANX POLR2B PBDC1 DZIP1 RRBP1 GPRIN1 SIRT1 PPM1G STAU1 CCDC88A IGF2R GLS STAU2 MTR DLD AKAP13 EIF4G3 AKAP1 TMCC1 HSPA9 PUS7 SOD1 | 1.81e-07 | 1487 | 178 | 25 | 33957083 | |
| Pubmed | LUC7L3 DOCK9 POLR2B ARHGEF12 GPATCH8 BIRC6 SIRT1 KMT2C SLTM AKAP13 USF2 ZNF292 | 1.82e-07 | 335 | 178 | 12 | 15741177 | |
| Pubmed | 1.82e-07 | 215 | 178 | 10 | 35973513 | ||
| Pubmed | ZFYVE16 SYNE1 DOCK9 PPP1R9A ARHGEF12 DDN GON4L GPATCH8 KANK1 CADPS NFAT5 CLEC16A PDZD2 | 2.06e-07 | 407 | 178 | 13 | 12693553 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TTF2 RANBP2 ZNF609 LUC7L3 ORC3 SPTA1 POLR2B NSD1 GPATCH4 CHD3 GPATCH8 RRBP1 RFC4 HMGN3 KMT2C DST RGPD3 SLTM HLTF ZFR USF2 CABIN1 HSPA9 | 2.25e-07 | 1294 | 178 | 23 | 30804502 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | TTF2 LUC7L3 GPATCH4 GPATCH8 RRBP1 RFC4 STAU1 CEP170 IGF2BP2 PKM HLTF SMARCC2 CWF19L1 HSPA9 | 2.43e-07 | 486 | 178 | 14 | 30940648 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP2 ABL2 SYNE1 PPP1R9A AAK1 ANKS1B DDN GPRIN1 GSN PITPNM1 RIMS1 | 2.49e-07 | 281 | 178 | 11 | 28706196 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.51e-07 | 123 | 178 | 8 | 26912792 | |
| Pubmed | PRUNE2 DCDC2 SYNE1 DOCK9 RRBP1 BIRC6 KMT2C DST CADPS CLEC16A | 2.77e-07 | 225 | 178 | 10 | 12168954 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | RANBP2 AARS1 CANX POLR2B TSC2 BIRC6 SIRT1 PPM1G CCDC88A IGF2R NCAPD2 PKM MTR HSPA9 RGPD5 | 2.89e-07 | 571 | 178 | 15 | 37167062 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 AARS1 LUC7L3 AIMP1 SYNE1 CANX POLR2B GPATCH4 RRBP1 RFC4 STAU1 LONP1 IGF2R RDH11 GLS NCAPD2 SLTM PKM MTR DLD ZFR MYO18B HSPA9 HDGF | 3.17e-07 | 1425 | 178 | 24 | 30948266 |
| Pubmed | RANBP2 SYNE1 DOCK9 GON4L ZNF407 DZIP1 BIRC6 CEP170 DST MED12L PKM MYO18B AKAP1 HSPA9 | 3.18e-07 | 497 | 178 | 14 | 23414517 | |
| Pubmed | ZNF609 AIMP1 KRT74 CANX RGPD1 GON4L GPATCH4 CHD3 LHX3 GPATCH8 SIRT1 PPM1G STAU1 KMT2C LONP1 IGF2BP2 DST STAU2 MTR SMARCC2 DLD ZFR ZFHX3 CABIN1 | 3.34e-07 | 1429 | 178 | 24 | 35140242 | |
| Pubmed | CANX PFDN2 GPATCH8 RRBP1 RFC4 SIRT1 PPM1G IGF2R PKM SMARCC2 PUS7 SOD1 HDGF | 3.37e-07 | 425 | 178 | 13 | 24999758 | |
| Pubmed | 3.98e-07 | 234 | 178 | 10 | 36243803 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RGPD8 RBBP8 CANX SIRT1 RUFY3 PPM1G CDC7 CCDC88A HOOK1 MTR SASS6 DLD CLSPN CFAP44 OBI1 | 4.18e-07 | 588 | 178 | 15 | 38580884 |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 9480752 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TTF2 RANBP2 AIMP1 POLR2B RFC4 BIRC6 STAU1 IGF2BP2 WDHD1 RDH11 RGPD3 STAU2 PKM ZFR TBC1D23 EIF4G3 | 7.83e-07 | 704 | 178 | 16 | 29955894 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 RGPD8 CANX RRBP1 TRIM29 GSN STAU1 CEP170 IGF2BP2 RGPD3 PKM NFAT5 HSPA9 RGPD5 | 9.15e-07 | 626 | 178 | 15 | 33644029 |
| Pubmed | LUC7L3 CANX POLR2B AAK1 GON4L GPATCH4 PFDN2 RRBP1 SIRT1 PPM1G LONP1 DST STAU2 HSPA9 | 9.92e-07 | 547 | 178 | 14 | 37267103 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RANBP2 AIMP1 ORC3 GON4L CHD3 RRBP1 RFC4 PPM1G SHPRH HLTF SMARCC2 ZFR | 1.01e-06 | 394 | 178 | 12 | 27248496 |
| Pubmed | TTF2 AARS1 LUC7L3 AIMP1 CANX PFDN2 RRBP1 RFC4 STAU1 CEP170 LONP1 IGF2R NCAPD2 PKM DLD NFAT5 HSPA9 | 1.02e-06 | 809 | 178 | 17 | 32129710 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 ZNF609 AAK1 GPATCH4 PFDN2 RRBP1 GSN STAU1 CEP170 HAUS8 IGF2BP2 STAU2 AKAP13 ZFR EIF4G3 ZNF292 | 1.13e-06 | 724 | 178 | 16 | 36232890 |
| Pubmed | 1.13e-06 | 203 | 178 | 9 | 35012549 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CACNA1B RANBP2 ARHGEF12 NEDD1 F5 PPM1G STAU1 CADPS STAU2 PKM DLD ZFR NFAT5 | 1.17e-06 | 475 | 178 | 13 | 31040226 |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 31376680 | ||
| Interaction | RGPD4 interactions | 5.25e-10 | 22 | 176 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 2.63e-09 | 27 | 176 | 7 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 9.59e-09 | 49 | 176 | 8 | int:RGPD1 | |
| Interaction | KCNA3 interactions | CACNA1B TTF2 RANBP2 ABL2 ZFYVE16 TMEM51 CANX AAK1 ARHGEF12 RRBP1 GPRIN1 PPM1G STAU1 CDC7 CEP170 KMT2C CCDC88A IGF2R DST HOOK1 NCAPD2 PKM RIMS1 EIF4G3 HSPA9 HDGF TDRD12 | 1.01e-08 | 871 | 176 | 27 | int:KCNA3 |
| Interaction | NUP43 interactions | RANBP2 ZNF609 RGPD8 LUC7L3 RBBP8 NSD1 GON4L GPATCH4 PFDN2 CHD3 GPATCH8 FSIP2 CCDC88A DST HOOK1 HLTF ZFHX3 EIF4G3 ZNF292 RGPD5 PDZD2 | 1.36e-07 | 625 | 176 | 21 | int:NUP43 |
| Interaction | RGPD3 interactions | 1.61e-07 | 47 | 176 | 7 | int:RGPD3 | |
| Interaction | RICTOR interactions | RGPD4 RGPD2 AARS1 RGPD8 RGPD1 TSC2 AARSD1 SIRT1 GSN PPM1G LONP1 IGF2BP2 IGF2R RDH11 RGPD3 PKM DLD NFAT5 CLEC16A OBI1 HSPA9 PUS7 RGPD5 | 2.10e-07 | 759 | 176 | 23 | int:RICTOR |
| Interaction | RGPD8 interactions | 2.66e-07 | 74 | 176 | 8 | int:RGPD8 | |
| Interaction | NAA40 interactions | TTF2 RANBP2 AARS1 ZFYVE16 PARG AAK1 GPATCH4 CHD3 RRBP1 RFC4 NEDD1 GPRIN1 STAU1 CEP170 IGF2BP2 DST STAU2 PKM DLD ZFR EIF4G3 AKAP1 HSPA9 PUS7 SOD1 | 1.40e-06 | 978 | 176 | 25 | int:NAA40 |
| Interaction | CEBPB interactions | RGPD4 RANBP2 AARS1 IMPDH1 LUC7L3 AIMP1 CANX POLR2B PBDC1 PFDN2 GPATCH8 RRBP1 RFC4 PPM1G STAU1 CEP170 IGF2BP2 WDHD1 GLS STAU2 PKM SMARCC2 DLD ZFR USF2 AKAP1 NFAT5 HSPA9 SOD1 ZNF292 HDGF | 2.68e-06 | 1443 | 176 | 31 | int:CEBPB |
| Interaction | SYNGAP1 interactions | DLGAP2 AAK1 ANKS1B DDN RRBP1 GPRIN1 BIRC6 RUFY3 CEP170 CCDC88A STAU2 AKAP13 EIF4G3 | 3.18e-06 | 307 | 176 | 13 | int:SYNGAP1 |
| Interaction | CLIP1 interactions | RANBP2 POLR2B CHD3 BIRC6 CCDC88A MAST4 CADPS RGPD3 PKM SYCE1 | 4.92e-06 | 183 | 176 | 10 | int:CLIP1 |
| Interaction | DCTN1 interactions | TTF2 DCDC2 POLR2B NEDD1 TRIM29 STAU1 CEP170 HAUS8 LONP1 IGF2BP2 CCDC88A DST HOOK1 WDHD1 NCAPD2 EML1 | 7.89e-06 | 497 | 176 | 16 | int:DCTN1 |
| Interaction | SIRT7 interactions | RANBP2 AARS1 CANX NSD1 BIRC6 SIRT1 PPM1G STAU1 CEP170 LONP1 IGF2BP2 IGF2R DST NCAPD2 SLTM SMARCC2 DLD ZFR EIF4G3 HSPA9 | 8.35e-06 | 744 | 176 | 20 | int:SIRT7 |
| Interaction | TPD52L2 interactions | 9.56e-06 | 156 | 176 | 9 | int:TPD52L2 | |
| Interaction | NUP50 interactions | RANBP2 RGPD8 NSD1 GPATCH4 PFDN2 TRIM29 SIRT1 PPM1G WDHD1 SMARCC2 ZFR CLSPN ZNF292 | 9.90e-06 | 341 | 176 | 13 | int:NUP50 |
| Interaction | H3C1 interactions | SYNE1 NSD1 GPATCH4 CHD3 RRBP1 RFC4 GPRIN1 TRIM29 SIRT1 PPM1G STAU1 KMT2C SHPRH SMARCC2 ZFR ZFHX3 CABIN1 CWF19L1 PUS7 ZNF292 HDGF PDZD2 | 1.30e-05 | 901 | 176 | 22 | int:H3C1 |
| Interaction | NPIPB6 interactions | 1.56e-05 | 18 | 176 | 4 | int:NPIPB6 | |
| Interaction | NRXN1 interactions | 1.60e-05 | 127 | 176 | 8 | int:NRXN1 | |
| Interaction | H2BC4 interactions | AIMP1 TRIM29 HMGN3 SIRT1 FSIP2 KMT2C WDHD1 SLTM SMARCC2 DLD HDGF | 1.81e-05 | 259 | 176 | 11 | int:H2BC4 |
| Interaction | RGPD5 interactions | 2.13e-05 | 96 | 176 | 7 | int:RGPD5 | |
| Interaction | API5 interactions | 4.21e-05 | 188 | 176 | 9 | int:API5 | |
| Interaction | EWSR1 interactions | PRUNE2 RHOXF2 CANX POLR2B PFDN2 CHD3 GPATCH8 RRBP1 RFC4 SIRT1 PPM1G TGOLN2 IGF2R PKM HLTF SMARCC2 ZFR PUS7 SOD1 ZNF292 HDGF | 4.45e-05 | 906 | 176 | 21 | int:EWSR1 |
| Interaction | ESRP1 interactions | 5.78e-05 | 77 | 176 | 6 | int:ESRP1 | |
| Interaction | FOXL1 interactions | 5.81e-05 | 196 | 176 | 9 | int:FOXL1 | |
| Interaction | CLTA interactions | ZFYVE16 CANX AAK1 NEDD1 TRIM29 TMPRSS11B STAU1 LONP1 IGF2BP2 IGF2R MAST4 HSPA9 | 6.31e-05 | 351 | 176 | 12 | int:CLTA |
| Interaction | RND1 interactions | 6.31e-05 | 246 | 176 | 10 | int:RND1 | |
| Interaction | SOHLH1 interactions | 6.82e-05 | 115 | 176 | 7 | int:SOHLH1 | |
| Interaction | BMI1 interactions | RANBP2 LUC7L3 SYNE1 CANX NSD1 TSC2 CHD3 GPATCH8 RRBP1 SIRT1 STAU1 IGF2BP2 DST STAU2 SLTM ZFR EIF4G3 | 6.86e-05 | 659 | 176 | 17 | int:BMI1 |
| Interaction | LNPK interactions | TOR1AIP2 SLC4A7 AIMP1 SYNE1 CANX NACAD TMPRSS11B PITPNM1 IGF2R CADPS OBI1 TMCC1 | 7.03e-05 | 355 | 176 | 12 | int:LNPK |
| Interaction | RCC1 interactions | 7.06e-05 | 201 | 176 | 9 | int:RCC1 | |
| Interaction | RAN interactions | RGPD4 RGPD2 RANBP2 RGPD8 AIMP1 RGPD1 CHD3 STAU1 CCDC88A RGPD3 SMARCC2 HSPA9 HDGF RGPD5 | 7.69e-05 | 475 | 176 | 14 | int:RAN |
| Interaction | RAC2 interactions | TOR1AIP2 SLC4A7 ABL2 ZFYVE16 DOCK9 CANX PPP1R9A RRBP1 GPRIN1 FZD6 LONP1 BMPR2 CCDC88A IGF2R DST MYO18B AKAP1 | 9.02e-05 | 674 | 176 | 17 | int:RAC2 |
| Interaction | BICD2 interactions | TTF2 RANBP2 ABL2 RGPD8 RGPD1 AAK1 NEDD1 STAU1 MAST4 SASS6 TSGA10IP SYCE1 RGPD5 | 9.86e-05 | 426 | 176 | 13 | int:BICD2 |
| Interaction | PRXL2A interactions | 1.15e-04 | 87 | 176 | 6 | int:PRXL2A | |
| Interaction | RCOR1 interactions | RANBP2 ZFYVE16 RBBP8 CHD3 BIRC6 CCDC88A DST WDHD1 NCAPD2 SMARCC2 ZFHX3 AKAP1 OBI1 HDGF | 1.16e-04 | 494 | 176 | 14 | int:RCOR1 |
| Interaction | NETO2 interactions | 1.17e-04 | 55 | 176 | 5 | int:NETO2 | |
| Interaction | NEMP1 interactions | 1.30e-04 | 89 | 176 | 6 | int:NEMP1 | |
| Interaction | RHOJ interactions | TOR1AIP2 SLC4A7 ABL2 ZFYVE16 TMEM51 DOCK9 CANX PPP1R9A GPRIN1 AARSD1 LONP1 BMPR2 CCDC88A IGF2R RDH11 GLS | 1.43e-04 | 633 | 176 | 16 | int:RHOJ |
| Interaction | BRD7 interactions | TTF2 LUC7L3 RGPD1 GPATCH4 LHX3 GPATCH8 RRBP1 RFC4 STAU1 CEP170 IGF2BP2 PKM HLTF SMARCC2 CWF19L1 HSPA9 | 1.53e-04 | 637 | 176 | 16 | int:BRD7 |
| Interaction | MCM2 interactions | RGPD4 RGPD2 RANBP2 RGPD8 SYNE1 TCP11L1 RGPD1 PFDN2 CHD3 STAU1 CDC7 IGF2BP2 DST WDHD1 RGPD3 GLS PKM CLSPN CABIN1 HSPA9 SOD1 RGPD5 | 1.93e-04 | 1081 | 176 | 22 | int:MCM2 |
| Interaction | BAP1 interactions | RANBP2 AARS1 LUC7L3 AIMP1 TCP11L1 CANX POLR2B PFDN2 RFC4 GSN PPM1G STAU1 CEP170 KMT2C IGF2BP2 DST HOOK1 STAU2 NCAPD2 PKM EIF4G3 OBI1 HSPA9 SOD1 HDGF | 1.95e-04 | 1314 | 176 | 25 | int:BAP1 |
| Interaction | KCTD13 interactions | DLGAP2 PDE1C SYNE1 SPTA1 PPP1R9A AAK1 ANKS1B ARHGEF12 PFDN2 CHD3 RRBP1 RUFY3 GSN STAU1 PITPNM1 CEP170 LONP1 DST CADPS PKM SMARCC2 DLD RIMS1 EIF4G3 HSPA9 SOD1 | 1.97e-04 | 1394 | 176 | 26 | int:KCTD13 |
| Interaction | C9orf72 interactions | RGPD4 TOR1AIP2 TTF2 RGPD2 RANBP2 RGPD8 AIMP1 CANX POLR2B PBDC1 RGPD1 TSC2 RRBP1 RFC4 BIRC6 PPM1G TGOLN2 CDC7 RGPD3 PKM HLTF MTR DLD HSPA9 RGPD5 | 2.07e-04 | 1319 | 176 | 25 | int:C9orf72 |
| Interaction | GOLGA1 interactions | 2.11e-04 | 183 | 176 | 8 | int:GOLGA1 | |
| Interaction | FHIP2B interactions | 2.12e-04 | 34 | 176 | 4 | int:FHIP2B | |
| Interaction | CEBPA interactions | TTF2 RANBP2 AARS1 ZNF609 ORC3 PFDN2 CHD3 RFC4 NEDD1 SIRT1 GSN PPM1G STAU1 CEP170 KMT2C IGF2BP2 PKM HLTF SMARCC2 ZFR USF2 HSPA9 ZNF292 HDGF | 2.18e-04 | 1245 | 176 | 24 | int:CEBPA |
| Interaction | BTF3 interactions | RGPD4 RANBP2 RGPD8 CANX POLR2B RRBP1 TRIM29 NACAD GSN STAU1 CEP170 LONP1 IGF2BP2 RGPD3 PKM NFAT5 HSPA9 RGPD5 | 2.28e-04 | 799 | 176 | 18 | int:BTF3 |
| Interaction | ITM2C interactions | 2.33e-04 | 99 | 176 | 6 | int:ITM2C | |
| Interaction | HEXB interactions | 2.41e-04 | 64 | 176 | 5 | int:HEXB | |
| Interaction | H2BC3 interactions | RANBP2 AIMP1 ORC3 GON4L CHD3 RRBP1 HMGN3 PPM1G KMT2C HLTF SMARCC2 ZFR | 2.46e-04 | 406 | 176 | 12 | int:H2BC3 |
| Interaction | MYCBP2 interactions | RGPD8 PPP1R9A GSN TGOLN2 STAU1 TRANK1 DST SMARCC2 CLEC16A HSPA9 SOD1 | 2.99e-04 | 355 | 176 | 11 | int:MYCBP2 |
| Interaction | WDR62 interactions | 3.05e-04 | 104 | 176 | 6 | int:WDR62 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.92e-08 | 115 | 123 | 9 | 769 | |
| GeneFamily | PDZ domain containing | 8.13e-05 | 152 | 123 | 7 | 1220 | |
| GeneFamily | PHD finger proteins | 3.72e-04 | 90 | 123 | 5 | 88 | |
| GeneFamily | SIBLING family | 4.53e-04 | 5 | 123 | 2 | 1279 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.20e-03 | 31 | 123 | 3 | 81 | |
| GeneFamily | Doublecortin superfamily | 1.99e-03 | 10 | 123 | 2 | 1369 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 8.29e-08 | 33 | 177 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.32e-07 | 43 | 177 | 6 | MM3857 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 CACNA1D RANBP2 AARS1 SLC4A7 ORC3 RBBP8 CANX RUFY3 GSN TGOLN2 KMT2C DST MAST4 HOOK1 CADPS HLTF PRKCH EIF4G3 HSPA9 ZNF292 PDZD2 | 4.67e-07 | 946 | 177 | 22 | M39169 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 SLC4A7 ZFYVE16 DOCK9 POLR2B PARG GPATCH8 CEP170 IGF2R DST WDHD1 STAU2 HLTF MTR AKAP13 ZFHX3 EIF4G3 CLEC16A TMCC1 ZNF292 | 1.51e-06 | 856 | 177 | 20 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 3.29e-06 | 176 | 177 | 9 | M39223 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RANBP2 ZNF609 SLC4A7 SYNE1 DOCK9 POLR2B AAK1 SERTAD2 NSD1 CHD3 GPATCH8 BIRC6 TGOLN2 PCNX2 KMT2C CCDC88A TRANK1 GLS MTR AKAP13 ZFR PRKCH ARHGAP25 USF2 NFAT5 ZNF292 | 8.57e-06 | 1492 | 177 | 26 | M40023 |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 8.92e-06 | 199 | 177 | 9 | M7259 | |
| Coexpression | GSE13229_IMM_VS_MATURE_NKCELL_UP | 9.28e-06 | 200 | 177 | 9 | M3205 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 2.29e-05 | 84 | 177 | 6 | M13008 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.21e-05 | 180 | 177 | 8 | M8239 | |
| Coexpression | FISCHER_DREAM_TARGETS | TTF2 AARS1 ORC3 GPATCH4 RFC4 NEDD1 BIRC6 CDC7 HAUS8 LONP1 WDHD1 NCAPD2 HLTF SASS6 CLSPN OBI1 CWF19L1 HSPA9 HDGF | 3.26e-05 | 969 | 177 | 19 | M149 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 3.34e-05 | 181 | 177 | 8 | M39225 | |
| Coexpression | IL2_UP.V1_DN | 5.27e-05 | 193 | 177 | 8 | M2820 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | TTF2 SLC4A7 IMPDH1 CANX SERTAD2 GPATCH4 RFC4 TRIM29 TGOLN2 CDC7 FZD6 HAUS8 HOOK1 WDHD1 NCAPD2 KICS2 SASS6 CLSPN PUS7 | 6.73e-05 | 1023 | 177 | 19 | M17122 |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN | 6.77e-05 | 200 | 177 | 8 | M9408 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 6.77e-05 | 200 | 177 | 8 | M8614 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 8.32e-05 | 206 | 177 | 8 | M39254 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RGPD2 RANBP2 RGPD8 AIMP1 DOCK9 RGPD1 GON4L RUFY3 RGPD3 ZFR RGPD5 | 9.75e-05 | 474 | 177 | 12 | M40991 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | TTF2 AARS1 RBBP8 CHD3 RFC4 GSN IGF2BP2 CCDC88A WDHD1 NCAPD2 HLTF CLSPN | 1.05e-04 | 478 | 177 | 12 | M45785 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PRUNE2 CACNA1D SLC26A3 LUC7L3 ANKS1B GON4L DZIP1 GHR IGF2BP2 AKAP13 PDZD2 | 1.33e-04 | 417 | 177 | 11 | M39224 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.35e-04 | 221 | 177 | 8 | M39222 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 1.54e-04 | 118 | 177 | 6 | M15305 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.68e-04 | 171 | 177 | 7 | M39234 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.03e-06 | 108 | 174 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | AMBP CACNA1B CACNA1D IRX5 SPTA1 CANX TRIM29 CEP170 FZD6 DST CADPS SCN3A HLTF AKAP13 PRKCH ZFHX3 RIMS1 NFAT5 SPINK5 | 1.90e-05 | 769 | 174 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 3.72e-05 | 152 | 174 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1D SLC4A7 NSD1 KDM5D HMGN3 KMT2C DST CADPS PKM PDE5A ZFR UTY | 2.41e-11 | 195 | 178 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-09 | 195 | 178 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.16e-09 | 199 | 178 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | DOCK9 PPP1R9A ARHGEF12 BIRC6 KMT2C BMPR2 IGF2BP2 DST MAST4 PRKCH | 8.56e-09 | 200 | 178 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CACNA1B CACNA1D DLGAP2 SYNE1 AAK1 ANKS1B CADPS GLS SCN3A RIMS1 | 8.56e-09 | 200 | 178 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.80e-08 | 193 | 178 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.20e-08 | 194 | 178 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.20e-08 | 194 | 178 | 9 | 0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.20e-08 | 194 | 178 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-08 | 195 | 178 | 9 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-07 | 196 | 178 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 198 | 178 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 198 | 178 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-07 | 188 | 178 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-06 | 190 | 178 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.05e-06 | 191 | 178 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 191 | 178 | 8 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-06 | 192 | 178 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.13e-06 | 193 | 178 | 8 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 193 | 178 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-06 | 193 | 178 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-06 | 193 | 178 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.13e-06 | 193 | 178 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 194 | 178 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 196 | 178 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 196 | 178 | 8 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 196 | 178 | 8 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 197 | 178 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 198 | 178 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 198 | 178 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-06 | 199 | 178 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.20e-06 | 156 | 178 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.32e-06 | 173 | 178 | 7 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.56e-06 | 174 | 178 | 7 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 178 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.07e-06 | 176 | 178 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.33e-06 | 177 | 178 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-06 | 178 | 178 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.49e-06 | 181 | 178 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 9.78e-06 | 185 | 178 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.01e-05 | 186 | 178 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-05 | 186 | 178 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 187 | 178 | 7 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.09e-05 | 188 | 178 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.09e-05 | 188 | 178 | 7 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.09e-05 | 188 | 178 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 188 | 178 | 7 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.16e-05 | 190 | 178 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 190 | 178 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.16e-05 | 190 | 178 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 178 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.20e-05 | 191 | 178 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 191 | 178 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Treg|normal_Lymph_Node / Location, Cell class and cell subclass | 1.25e-05 | 192 | 178 | 7 | d2c2a98d331522a3ab7973bfaf4396ef4d684888 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.25e-05 | 192 | 178 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.25e-05 | 192 | 178 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-05 | 192 | 178 | 7 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 192 | 178 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.28e-05 | 128 | 178 | 6 | 3ca9ae69fb8cb7f8acb7540aa71778bc917da4df | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 193 | 178 | 7 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 193 | 178 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 193 | 178 | 7 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 193 | 178 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-05 | 193 | 178 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.29e-05 | 193 | 178 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 193 | 178 | 7 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.33e-05 | 194 | 178 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 194 | 178 | 7 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.33e-05 | 194 | 178 | 7 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 194 | 178 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 195 | 178 | 7 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.42e-05 | 196 | 178 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 196 | 178 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 196 | 178 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 196 | 178 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.47e-05 | 197 | 178 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.47e-05 | 197 | 178 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Transverse-T_cell-Treg|T_cell / Region, Cell class and subclass | 1.47e-05 | 197 | 178 | 7 | b7a1637e4baadd657f6279f4aa96cd590c9cd8c9 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.47e-05 | 197 | 178 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-05 | 198 | 178 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 198 | 178 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.62e-05 | 200 | 178 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| Drug | Magnetite Nanoparticles | CACNA1B SLC4A7 PUS3 LUC7L3 ZFYVE16 ORC3 RBBP8 TMEM51 CANX NSD1 GPATCH4 TRIM29 RUFY3 GSN CDC7 PITPNM1 CEP170 IGF2BP2 NLRP10 CCDC88A WDHD1 CADPS SLTM ZFR CLSPN NFAT5 UTY SOD1 ZNF292 | 3.25e-07 | 1310 | 177 | 29 | ctd:D058185 |
| Drug | Succimer | CACNA1B SLC4A7 PUS3 LUC7L3 ZFYVE16 ORC3 RBBP8 TMEM51 CANX NSD1 GPATCH4 TRIM29 RUFY3 GSN CDC7 PITPNM1 CEP170 IGF2BP2 NLRP10 CCDC88A WDHD1 CADPS SLTM ZFR CLSPN NFAT5 UTY ZNF292 | 5.27e-07 | 1264 | 177 | 28 | ctd:D004113 |
| Drug | AC1O5G8G | 1.84e-06 | 4 | 177 | 3 | CID006433453 | |
| Drug | testosterone enanthate | PRUNE2 RANBP2 PDE1C SLC4A7 LUC7L3 PPP1R9A GPATCH8 RRBP1 ABCA7 RUFY3 TGOLN2 IGF2R PDE5A AKAP13 EIF4G3 NFAT5 FAM149A | 2.73e-06 | 575 | 177 | 17 | ctd:C004648 |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A | PDE1C ZNF609 BMPR2 AKAP13 EML1 EIF4G3 USF2 NFAT5 UTY CWF19L1 | 3.00e-06 | 194 | 177 | 10 | 5104_DN |
| Drug | 4-methyl-1,10-phenanthroline | 1.58e-05 | 7 | 177 | 3 | CID000093149 | |
| Drug | di-O-p | 1.58e-05 | 7 | 177 | 3 | CID000033934 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.78e-05 | 189 | 177 | 9 | 5084_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.94e-05 | 191 | 177 | 9 | 4269_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 2.11e-05 | 193 | 177 | 9 | 6920_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 2.20e-05 | 194 | 177 | 9 | 1924_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 2924_UP | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; HL60; HG-U133A | 2.29e-05 | 195 | 177 | 9 | 2025_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 5728_DN | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 1146_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 1686_DN | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 2644_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A | PDE1C IMPDH1 ARHGEF12 PITPNM1 SMARCC2 USF2 NFAT5 OBI1 ZNF292 | 2.58e-05 | 198 | 177 | 9 | 7275_DN |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 5457_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 2128_UP | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; PC3; HG-U133A | 2.68e-05 | 199 | 177 | 9 | 1959_UP | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; HL60; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 1295_DN | |
| Drug | AC1L3TPS | 5.33e-05 | 10 | 177 | 3 | CID000121952 | |
| Drug | DEAPA | 6.01e-05 | 2 | 177 | 2 | CID000061011 | |
| Drug | DMAPA | 6.01e-05 | 2 | 177 | 2 | CID000135080 | |
| Drug | benzoate | 6.07e-05 | 221 | 177 | 9 | CID000000242 | |
| Drug | epoxiconazole | CACNA1B CACNA1D LUC7L3 RBBP8 TSC2 F5 GHR IGF2R GLS AKAP13 AKAP1 | 7.75e-05 | 341 | 177 | 11 | ctd:C109476 |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.59e-05 | 183 | 177 | 8 | 5613_DN | |
| Drug | Span 85 | 9.65e-05 | 12 | 177 | 3 | CID006435912 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 1.07e-04 | 186 | 177 | 8 | 2684_UP | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 1.16e-04 | 188 | 177 | 8 | 7097_DN | |
| Drug | EGTA-AM | 1.21e-04 | 62 | 177 | 5 | CID000121907 | |
| Drug | AC1NUZ2Z | 1.25e-04 | 13 | 177 | 3 | CID005464257 | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.29e-04 | 191 | 177 | 8 | 4273_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.39e-04 | 193 | 177 | 8 | 4670_UP | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 1.44e-04 | 194 | 177 | 8 | 6165_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.44e-04 | 194 | 177 | 8 | 2433_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 7225_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 4396_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 2432_DN | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 2152_UP | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 1794_DN | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 6295_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 3032_DN | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 3031_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 5290_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 7408_UP | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2812_DN | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 4796_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 3004_DN | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2992_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 3459_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2342_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; HL60; HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2003_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 7286_DN | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2103_UP | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 7095_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 7096_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; HL60; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 1300_UP | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 6603_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 3170_UP | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 1868_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 6682_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HG-U133A | 1.65e-04 | 198 | 177 | 8 | 1917_UP | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 6346_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 3024_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HG-U133A | 1.65e-04 | 198 | 177 | 8 | 310_UP | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; HL60; HG-U133A | 1.65e-04 | 198 | 177 | 8 | 1766_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.71e-04 | 199 | 177 | 8 | 7263_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A | 1.71e-04 | 199 | 177 | 8 | 2449_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.71e-04 | 199 | 177 | 8 | 4297_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A | 1.71e-04 | 199 | 177 | 8 | 2498_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 1.77e-04 | 200 | 177 | 8 | 665_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.77e-04 | 200 | 177 | 8 | 5853_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A | 1.77e-04 | 200 | 177 | 8 | 453_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.77e-04 | 200 | 177 | 8 | 3432_DN | |
| Drug | 5,6-dimethyl-1,10-phenanthroline | 1.79e-04 | 3 | 177 | 2 | CID000076357 | |
| Drug | CHDM | 1.79e-04 | 3 | 177 | 2 | CID000007735 | |
| Drug | endosulfan diol | 1.79e-04 | 3 | 177 | 2 | CID000092170 | |
| Drug | Wang resin | 1.79e-04 | 3 | 177 | 2 | CID000070043 | |
| Disease | Intellectual Disability | CACNA1B PUS3 SYNE1 NSD1 GON4L CHD3 KMT2C SCN3A MED12L SMARCC2 TBC1D23 PUS7 ZNF292 | 2.15e-06 | 447 | 170 | 13 | C3714756 |
| Disease | urate measurement | A1CF DSPP AAK1 NSD1 GON4L CHD3 TRIM29 BIRC6 MEPE BMPR2 IGF2BP2 STAU2 ADAMTS17 AKAP13 MYO18B NFAT5 TSGA10IP TDRD12 | 4.58e-06 | 895 | 170 | 18 | EFO_0004531 |
| Disease | protein SEC13 homolog measurement | 3.30e-05 | 2 | 170 | 2 | EFO_0801961 | |
| Disease | junctophilin-1 measurement | 9.86e-05 | 3 | 170 | 2 | EFO_0802667 | |
| Disease | guanylyl cyclase-activating protein 1 measurement | 1.96e-04 | 4 | 170 | 2 | EFO_0801663 | |
| Disease | E3 ubiquitin-protein ligase DTX1 measurement | 1.96e-04 | 4 | 170 | 2 | EFO_0802503 | |
| Disease | coagulation factor V measurement | 1.99e-04 | 20 | 170 | 3 | EFO_0008087 | |
| Disease | prothrombin time measurement | 2.32e-04 | 21 | 170 | 3 | EFO_0008390 | |
| Disease | FEV/FEC ratio | CACNA1D PDE1C DSPP DOCK9 SERTAD2 ANKS1B NSD1 ZC3H11B RRBP1 MEAK7 TG IGF2BP2 KANK1 DST PLXDC2 CADPS ZFHX3 CLEC16A | 2.73e-04 | 1228 | 170 | 18 | EFO_0004713 |
| Disease | cadherin-7 measurement | 3.26e-04 | 5 | 170 | 2 | EFO_0801438 | |
| Disease | STROKE, ISCHEMIC | 3.26e-04 | 5 | 170 | 2 | 601367 | |
| Disease | Ischemic stroke | 3.26e-04 | 5 | 170 | 2 | cv:C0948008 | |
| Disease | cytochrome c oxidase subunit 6C measurement | 4.88e-04 | 6 | 170 | 2 | EFO_0801515 | |
| Disease | torsin-1A-interacting protein 1 measurement | 4.88e-04 | 6 | 170 | 2 | EFO_0802137 | |
| Disease | solute carrier family 22 member 16 measurement | 4.88e-04 | 6 | 170 | 2 | EFO_0802079 | |
| Disease | Microcephaly | 6.14e-04 | 67 | 170 | 4 | C0025958 | |
| Disease | surfeit locus protein 1 measurement | 6.80e-04 | 7 | 170 | 2 | EFO_0802105 | |
| Disease | tissue factor pathway inhibitor measurement | 6.80e-04 | 7 | 170 | 2 | EFO_0007968 | |
| Disease | mean corpuscular hemoglobin concentration | SPTA1 SERTAD2 GON4L TSC2 MEAK7 ABCA7 HAUS8 LONP1 BMPR2 HOOK1 WDHD1 RP1L1 AKAP13 CLSPN EIF4G3 USF2 | 6.86e-04 | 1105 | 170 | 16 | EFO_0004528 |
| Disease | obsolete_red blood cell distribution width | SPTA1 RGPD1 SERTAD2 ZNF407 LHX3 BIRC6 ABCA7 CEP170 LONP1 BMPR2 IGF2BP2 FANK1 MAST4 HOOK1 RP1L1 AKAP13 EIF4G3 USF2 | 8.06e-04 | 1347 | 170 | 18 | EFO_0005192 |
| Disease | neutrophil percentage of leukocytes | SPTA1 FAM83E ABCA7 AARSD1 TGOLN2 AKAP13 ARHGAP25 BCL2L13 CLEC16A XKR5 ZNF292 | 8.63e-04 | 610 | 170 | 11 | EFO_0007990 |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 9.03e-04 | 8 | 170 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | urate measurement, bone density | DLGAP2 LUC7L3 SYNE1 PARG SERTAD2 TG FSIP2 MAST4 ARHGAP25 CABIN1 PDZD2 | 9.72e-04 | 619 | 170 | 11 | EFO_0003923, EFO_0004531 |
| Disease | bilirubin measurement | 1.11e-03 | 442 | 170 | 9 | EFO_0004570 | |
| Disease | interleukin 25 measurement | 1.16e-03 | 9 | 170 | 2 | EFO_0008182 | |
| Disease | Chronic schizophrenia | 1.16e-03 | 9 | 170 | 2 | C0221765 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.20e-03 | 447 | 170 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | Vertigo | 1.29e-03 | 139 | 170 | 5 | HP_0002321 | |
| Disease | body surface area | RGPD1 AAK1 NSD1 ARHGEF12 ZC3H11B LHX3 GHR IGF2BP2 ADAMTS17 AKAP13 ZFHX3 | 1.32e-03 | 643 | 170 | 11 | EFO_0022196 |
| Disease | BMI-adjusted waist-hip ratio, asthma | 1.44e-03 | 10 | 170 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | osteoarthritis, knee, body mass index | 1.71e-03 | 41 | 170 | 3 | EFO_0004340, EFO_0004616 | |
| Disease | Posterior Choroidal Artery Infarction | 1.75e-03 | 11 | 170 | 2 | C0887799 | |
| Disease | Cerebral Infarction, Left Hemisphere | 1.75e-03 | 11 | 170 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 1.75e-03 | 11 | 170 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 1.75e-03 | 11 | 170 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 1.75e-03 | 11 | 170 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 1.75e-03 | 11 | 170 | 2 | C0007785 | |
| Disease | Diabetic Retinopathy | 1.75e-03 | 11 | 170 | 2 | C0011884 | |
| Disease | Autoimmune Diseases | 1.83e-03 | 42 | 170 | 3 | C0004364 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | forced expiratory volume | CACNA1D RBBP8 SYNE1 DOCK9 LHX3 ARMS2 IGF2BP2 DST ADAMTS17 NFAT5 TSGA10IP CLEC16A | 2.15e-03 | 789 | 170 | 12 | EFO_0004314 |
| Disease | vital capacity | DSPP RBBP8 SYNE1 POLR2B LHX3 STAU1 GHR ARMS2 IGF2BP2 DST ADAMTS17 ZFHX3 MYO18B NFAT5 TSGA10IP PDZD2 | 2.17e-03 | 1236 | 170 | 16 | EFO_0004312 |
| Disease | selective IgA deficiency disease | 2.38e-03 | 46 | 170 | 3 | EFO_1001929 | |
| Disease | alcohol and nicotine codependence | 2.47e-03 | 13 | 170 | 2 | EFO_0004776 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.47e-03 | 13 | 170 | 2 | EFO_0802114 | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.47e-03 | 13 | 170 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 2.47e-03 | 13 | 170 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | body weight | CACNA1B AARS1 PDE1C DSPP RGPD1 AAK1 ANKS1B ARHGEF12 GON4L GHR IGF2BP2 MAST4 CADPS ADAMTS17 ZFHX3 PDZD2 | 2.65e-03 | 1261 | 170 | 16 | EFO_0004338 |
| Disease | uric acid measurement | DCDC2 A1CF AAK1 BIRC6 F5 BMPR2 IGF2BP2 AKAP13 NFAT5 TSGA10IP | 2.94e-03 | 610 | 170 | 10 | EFO_0004761 |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.19e-03 | 171 | 170 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | 3-hydroxyanthranilic acid measurement | 3.30e-03 | 15 | 170 | 2 | EFO_0010447 | |
| Disease | hemoglobin A1 measurement | 3.32e-03 | 520 | 170 | 9 | EFO_0007629 | |
| Disease | platelet crit | SLC4A7 SERTAD2 ARHGEF12 ZNF407 GPATCH8 RRBP1 MEAK7 CDC7 IGF2BP2 MAST4 HOOK1 PDE5A ARHGAP25 | 3.60e-03 | 952 | 170 | 13 | EFO_0007985 |
| Disease | Abnormal behavior | 3.76e-03 | 16 | 170 | 2 | C0233514 | |
| Disease | Acute Cerebrovascular Accidents | 3.76e-03 | 54 | 170 | 3 | C0751956 | |
| Disease | Autistic Disorder | 4.15e-03 | 261 | 170 | 6 | C0004352 | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 4.24e-03 | 17 | 170 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | age at onset, Parkinson disease | 4.75e-03 | 18 | 170 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | corneal resistance factor | SERTAD2 ARHGEF12 ZC3H11B ZNF407 CEP170 ARMS2 ADAMTS17 AKAP13 | 4.78e-03 | 451 | 170 | 8 | EFO_0010067 |
| Disease | waist-hip ratio | PRUNE2 NSD1 ZC3H11B ZNF407 BIRC6 HAUS8 IGF2BP2 MAST4 CADPS GLS PDE5A RIMS1 TBC1D23 NFAT5 CLEC16A | 5.00e-03 | 1226 | 170 | 15 | EFO_0004343 |
| Disease | diet measurement, HOMA-B | 5.29e-03 | 19 | 170 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Cerebrovascular accident | 5.54e-03 | 62 | 170 | 3 | C0038454 | |
| Disease | serum urea measurement | 5.55e-03 | 195 | 170 | 5 | EFO_0009795 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.55e-03 | 195 | 170 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | pain | 5.67e-03 | 196 | 170 | 5 | EFO_0003843 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKSLDSNGAGEKSEN | 286 | Q9BXK5 | |
| GGGQLVTEVTKKEDS | 216 | P02760 | |
| NGETLKTGGDNKTLL | 706 | Q5SW79 | |
| VGGEGASDKQRSKLS | 46 | P0C7Q2 | |
| GEEDKGKSSSSQVVG | 241 | Q92667 | |
| FDGNSSKGGLGKEES | 256 | Q8IYS0 | |
| DEEKVSGGKDGNGSS | 2956 | Q9NR09 | |
| TVIDTKDGSQSKLGG | 671 | Q99708 | |
| AGQSTSETQEGGKKA | 1011 | P42684 | |
| SETQEGGKKAALGAV | 1016 | P42684 | |
| KSGDGLSGTQKEAAL | 6 | Q9NQ94 | |
| TAEKRKGGQTVDSGL | 756 | Q2M2I8 | |
| SSGTKEQIKGGTGDE | 106 | Q12904 | |
| TESDSGLKKGGNANL | 2496 | Q12802 | |
| LQTEGSNGKKEVLSG | 26 | Q9BTE6 | |
| EGSSKSNANGTKADG | 246 | Q9P1A6 | |
| SQDKGIEIKGPSSGN | 371 | Q9NZW4 | |
| SQSKPGKEEGEGATV | 491 | O94850 | |
| SGNVDLESQAEGKKE | 1096 | Q00975 | |
| ESSGGTENKAGGKVE | 1426 | Q96F81 | |
| SKDEKSPGVEQTGSG | 1286 | Q96MT7 | |
| GTALKDSGKGSINSD | 711 | Q8TE56 | |
| GSVDTRQEKKNGSQG | 1056 | Q8IZY2 | |
| SQEGGKENDTGSKQV | 676 | Q9NZN5 | |
| KENDTGSKQVGETSA | 681 | Q9NZN5 | |
| NDQTKVTEEENKGSG | 2186 | P49792 | |
| LVSGGSTHNSEKKGD | 956 | Q96L73 | |
| DQTKVTEEENKGSGT | 1211 | Q99666 | |
| DQTKVTEEENKGSGT | 1211 | O14715 | |
| ATSSDKVKDGGGGNE | 341 | P78411 | |
| GNSEGKELVASGENK | 116 | O94925 | |
| SKISEEELGKNGSQS | 361 | Q7Z6G8 | |
| EGGEKLQTDQAEASK | 426 | Q9ULU8 | |
| VVSGADKDGEGLSTQ | 236 | P32926 | |
| QGEKEQKENSELSTG | 721 | Q8NEZ4 | |
| NKKSTTETGVGDEGQ | 756 | Q86YW9 | |
| SLTSSDEGAKGQKGE | 76 | A8MXT2 | |
| DAVVNKGSDESIGKG | 416 | Q8NHV4 | |
| TGNKGFEDGDDAISK | 121 | Q9NQ76 | |
| DRTQNEKEDKASGGG | 566 | A5PLN7 | |
| QAEGGKGFSKTVNSS | 461 | Q8NI17 | |
| EVSEGTTGKGLDQKA | 1821 | Q6PRD1 | |
| TTGKGLDQKAGSESA | 1826 | Q6PRD1 | |
| GVSRQDGKGDSQEEK | 2031 | Q6PRD1 | |
| EGKDNIAGTQKEAST | 626 | Q86W26 | |
| NAKTGSQIGVKSEGE | 136 | Q9NQ38 | |
| GSDKVNGQSLETGSE | 2501 | Q03001 | |
| SGGTDKDISAKAVQD | 6116 | Q03001 | |
| VKDEQSGGGNVSSTL | 271 | Q9BY66 | |
| SLSEVSGGQKDNEKS | 3366 | Q5CZC0 | |
| VGNFGNSSGEVDTKK | 161 | Q69YN2 | |
| GSNSLEDGQTLGTKK | 1446 | Q3V6T2 | |
| REGTTKGNEKEDAAG | 256 | Q5T3I0 | |
| KGNEKEDAAGTSGLG | 261 | Q5T3I0 | |
| EKSSDQGLQKVGDSD | 336 | Q9UKJ3 | |
| VGDSDGSSNLDGKKE | 346 | Q9UKJ3 | |
| KENSEGAGAKASSAG | 136 | Q9UHV9 | |
| GSESKVGKEGQTNLD | 501 | A6NKB5 | |
| VGSEDVGTGPKNDNK | 266 | Q86W56 | |
| SGEEENTKNGGEKGA | 181 | Q9BVG4 | |
| NTKNGGEKGADSGEE | 186 | Q9BVG4 | |
| EAKSQAEEGASGKAE | 551 | Q14123 | |
| GAEESKGNLESPKQG | 481 | O15018 | |
| AKVGAKQGPSESGTE | 831 | Q9H5P4 | |
| KQGPSESGTEGTAKE | 836 | Q9H5P4 | |
| NKKSGNGGTFTEKDE | 286 | O76074 | |
| GKEGTAPSENGETKA | 71 | Q15651 | |
| KGNAEGSSDEEGKLV | 126 | P51858 | |
| GSKGSEEDVVSKNQG | 281 | Q5W0B1 | |
| ASGKAGDILSGDQDK | 11 | Q14678 | |
| GNDIGNEGASKISKG | 311 | Q0VAA2 | |
| NEGASKISKGLESNE | 316 | Q0VAA2 | |
| SGAAGPTGKNEEKIQ | 116 | O95232 | |
| EVENGGSLGSKKGVN | 196 | P14618 | |
| GGSKSDKDSVQEGQD | 236 | Q9UBR4 | |
| DAKGDKDGSLEVTGQ | 791 | P36776 | |
| GKGGKTVNELQNLTS | 526 | Q9Y6M1 | |
| VGDPSEEQLAKGNKS | 411 | Q6P9B6 | |
| GSGSSGTGEQKEDQK | 661 | P38646 | |
| KADSSGVGKGDLQST | 76 | Q9BT25 | |
| SSGDGEETGTQAKQI | 986 | O94916 | |
| SGQTEQTQKAGEGKR | 186 | Q9UBG3 | |
| QGVSGSIQDKGSIQK | 441 | P20839 | |
| GLSEQNGKGALKSER | 276 | Q86UR5 | |
| NVEKEREANKSAGGS | 36 | Q96MD2 | |
| NDQTKVAEEENKGSG | 1211 | A6NKT7 | |
| EQVDGKGQAGSVSES | 631 | O60353 | |
| TKTGQEESEAKTGQE | 746 | Q9UKF2 | |
| ATGKDLQGATEERGK | 1421 | Q9Y6J0 | |
| KDEDAASLGSQKGGI | 161 | Q9BZ29 | |
| EKSHSNLGVKDGDSG | 371 | P10912 | |
| KDGKEGSVGLSVQRS | 271 | O00311 | |
| GEGDGGQKQVEQKSS | 121 | Q12873 | |
| KGVGGNNPDEEKNST | 861 | Q68DX3 | |
| AKDSGTQAKGPEGEQ | 2116 | Q3T8J9 | |
| IGESTQDGKSGSGEK | 956 | Q13873 | |
| KQKSDAEEDGGTVSQ | 551 | P27824 | |
| ITGKNQVTATKADGG | 156 | P09622 | |
| GISGKGEGTEKSSQA | 1656 | O15021 | |
| VGTGASEAEKTGAQE | 606 | P06396 | |
| IATGQVAGTSKDGKQ | 286 | O00423 | |
| LGGNNTSEKADGLSK | 341 | Q14527 | |
| LQEQGSKSEGESSSK | 531 | Q9UJC3 | |
| ASGKAQPQSGGKAET | 626 | Q7Z2K8 | |
| STDKENGENVGLESK | 586 | Q6UVJ0 | |
| GEKKEQEGQTSETTA | 241 | O43432 | |
| QLTKETEGGNHSSGK | 216 | Q01668 | |
| VLDKERKSQGAGSGQ | 426 | Q9UHG0 | |
| DQTKVTEEENKGSGT | 1196 | P0DJD0 | |
| EDASGSQPKGLQKTD | 511 | Q9UBD5 | |
| NGTDVNLKNGSGKDS | 166 | Q8TC84 | |
| QGKEGQENGHITTKS | 2381 | P11717 | |
| NSSKGTEGDGQITAI | 246 | Q7L099 | |
| RGQSKKGQGSEESED | 81 | Q3SY00 | |
| NEAGKSKSNDSEEGL | 11 | Q9NUJ3 | |
| VNGEGLGKSQSSTKV | 801 | O14607 | |
| VTGANTGIGKETAKE | 46 | Q8TC12 | |
| GVAASAGSSGENKKA | 21 | P35249 | |
| NDQTKVTEEENKGSG | 1211 | Q7Z3J3 | |
| SGSLENGTKADGKDA | 26 | Q14134 | |
| NGTKADGKDAKTTNG | 31 | Q14134 | |
| TEDENKQSFLDGGKG | 86 | Q8NFQ8 | |
| KEDSNIRENSAGAGK | 36 | Q9BZE2 | |
| NLDNSKSGEIKGNGS | 386 | Q9Y6M7 | |
| ASGVENASGISEKGQ | 1346 | Q8WUY3 | |
| GKGEQALRSSNKEGQ | 2686 | Q8NF91 | |
| SQLSGSSDGDNELKK | 381 | Q2M2I3 | |
| GTLTEGGTQKTFDKQ | 196 | P12259 | |
| TKVTEEENKGSGTGA | 1206 | P0DJD1 | |
| GAESKTSSENQKPGG | 1151 | Q587J7 | |
| NSEVDGSLKKTTGGF | 971 | Q9NTG1 | |
| LSTEGAEENGNSDKK | 526 | O15355 | |
| QTQGTGGKKVIQTDE | 651 | Q99707 | |
| NGASTDDSAAEKKGG | 436 | Q6UX71 | |
| STGKGGKNSEAQLED | 66 | Q96PZ0 | |
| KDIAGSGDGTQEVSK | 196 | Q9NWH9 | |
| QGKVSANKGEIGDAT | 986 | P30876 | |
| LEKSQDKTSGGVNPE | 1416 | Q149N8 | |
| ENPDLKNVGSSTGEK | 596 | Q96EB6 | |
| IDKLNGNSTPEKTDG | 1946 | Q9NY46 | |
| EQGTAAGEKLKSAGA | 51 | P0C7M4 | |
| EKDGKIDFTINTNGG | 736 | P40879 | |
| DLGKGGNEESTKTGN | 126 | P00441 | |
| TGKDEDENSTGNKGE | 391 | Q8TAQ2 | |
| KGPKGEGLQENESST | 836 | Q86YF9 | |
| SQTNLVDLDLGGKGK | 136 | Q15021 | |
| SKLKESLDSGNQNGG | 381 | Q9NQ89 | |
| EGGSKGIKTSGESEE | 421 | Q2KHT3 | |
| DKENNDGSSEIGKAV | 696 | Q9HAW4 | |
| QKKSREESSGEGSGV | 26 | O00562 | |
| TPKDGSNKSGAEEQG | 216 | O43493 | |
| GEELSQAEATKAGGK | 1741 | Q9C0A1 | |
| EGITNQGKKAEGSPS | 561 | Q9P2E9 | |
| GGGKDVSAQATGKNV | 931 | P49588 | |
| TGNKIVNGKSSLEGA | 181 | Q86T26 | |
| GEFSAEGEGNSKKLS | 246 | Q9NUL3 | |
| GNHTAEGTGTNKKVA | 326 | O95793 | |
| SEGETQGEKKGSPQV | 2241 | Q8IWN7 | |
| AEETKGTAGKAINEG | 31 | A8MU46 | |
| VKGTSSEAGTQKLDG | 196 | Q14140 | |
| EKAGGQDTSSQKIED | 21 | Q8N0S2 | |
| ANKAKGETASEGTEA | 1066 | O75717 | |
| SETGPGKKNSGEEEI | 536 | P42331 | |
| EDKGSQEKQGKSEGE | 61 | Q6IPX3 | |
| EAQKQSIESGSIAGG | 381 | Q9NUY8 | |
| EKKENGLIGNTFSTG | 231 | P20061 | |
| LEVKSGSQGAGETSQ | 1771 | O60281 | |
| ASKKEVQGRSGDGAN | 116 | O15014 | |
| EKPTAQGSNKTEVGG | 41 | Q9NW97 | |
| IVNSVSGEGGDAKSQ | 1011 | O15015 | |
| GGKSQDAEARKQTES | 16 | O94876 | |
| EQGTAAGEKLKSAGA | 51 | Q9BQY4 | |
| DKETSLKTNGNGADL | 1946 | P02549 | |
| NADNSKTGASKGGIL | 266 | Q15853 | |
| KSGNAGEARSQTEKG | 401 | Q8IUG5 | |
| KEKSEEQGEGSSGVS | 226 | A0A1B0GTU1 | |
| GGNKLQSTGNKAEDI | 506 | Q96KR1 | |
| QSTGNKAEDIKGTEC | 511 | Q96KR1 | |
| GANDKKEEFDVSGNG | 781 | Q9C0G0 | |
| GSLEAGKKNAGSAVT | 926 | Q9C0G0 | |
| TPKEGADAVSGTQGK | 511 | Q6UX68 | |
| QSSEPLEAGAGKEGK | 711 | O15050 | |
| KTSADGAKGGQSAES | 2726 | P01266 | |
| ASQTKSESVEEKGGG | 1041 | Q68DK2 | |
| EKGNKGVISSVDGIS | 1391 | Q7Z3T8 | |
| NDSGEDFKLGTIKGQ | 1651 | P49815 | |
| SQVDNGSKKGGERLS | 796 | Q9UNY4 | |
| KDQEGGASSSQAEKE | 1171 | Q15911 | |
| KTTEARGGDLKDTQG | 501 | Q7RTS7 | |
| QGKESSKEGNGIGVN | 331 | P24723 | |
| QKTEEESGGGAKGLQ | 421 | O15069 | |
| GEQKTKEGEGSQQSR | 41 | Q9ULJ8 |